Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Lymphoma 46Lymphoma, Non-Hodgkin 33Lymphoma, Large B-Cell, Diffuse 32Lymphoma, Mantle-Cell 25Lymphoma, Follicular 21Hodgkin Disease 21Lymphoma, Large-Cell, Immunoblastic 16Glioblastoma 16Leukemia, Lymphocytic, Chronic, B-Cell 15Burkitt Lymphoma 15Brain Neoplasms 14Multiple Myeloma 13Gliosarcoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Central Nervous System Neoplasms 12Leukemia 10Neoplasms, Plasma Cell 9Lymphoma, B-Cell, Marginal Zone 9Glioma 9Astrocytoma 9Oligodendroglioma 5Waldenstrom Macroglobulinemia 4Recurrence 4Lymphoma, T-Cell 4Lymphoma, B-Cell 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 3Lymphoma, T-Cell, Peripheral 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3

Interventions

Ipilimumab 10pembrolizumab 7Nivolumab 7incomplete Freund's adjuvant 6Temozolomide 5Dacarbazine 5tebentafusp 4Sunitinib 4MART-1 Antigen 4Carboplatin 4CTLA-4 Antigen 4sargramostim 3montanide ISA 51 3aflibercept 3Paclitaxel 3Bevacizumab 3trametinib 2relatlimab 2olaparib 2lenvatinib 2cediranib 2Vorinostat 2Thalidomide 2Taxes 2Sorafenib 2Radiosurgery 2MAGEA3 protein, human 2Lenalidomide 2Interleukin-2 2Interleukin-12 Subunit p35 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Uveal Melanoma × Carmustine × Clear all
NCT04728633 2026-05-06

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Thomas Jefferson University

Phase 2 Active not recruiting
28 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡